Moreover, inhibition of TP53 by a TP53 inhibitor, PFTα, increased the ATO sensitivity of TP53 wildtype tumor cells, coincident with ATO‐induced cell growth arrest and cell apoptosis. This evidence concerns the gene TP53 and neoplasm.